Trial intelligence / Profile preview

Misoprostol for Prevention of Postpartum Haemorrhage

NCT02424201Phase 1Unknown

Sponsor
Lagos State University
Start
Jun 2015
Primary completion
Dec 2015
Modality
Small Molecules
01

Overview

Phase 1, randomised, double-blind trial in postpartum hemorrhage (PPH) comparing Misoprostol + Oxytocin with Placebo + Oxytocin (2 arms). Primary endpoint: Mean blood loss at 1 hour. Status: unknown.

02

Drugs

misoprostol
03

Conditions

postpartum hemorrhage (PPH)

Beyond the preview

Go deeper on NCT02424201.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02424201.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call